AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹331 Cr | ₹267 Cr | ₹249 Cr | ₹194 Cr | ₹185 Cr |
What is the latest Contingent Liabilities ratio of AARTI DRUGS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹331 Cr |
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹249 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹185 Cr |
How is Contingent Liabilities of AARTI DRUGS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹331 Cr | 23.87 | |
| Mar2025 | ₹267 Cr | 7.52 | |
| Mar2024 | ₹249 Cr | 28.21 | |
| Mar2023 | ₹194 Cr | 4.83 | |
| Mar2022 | ₹185 Cr | - | |
Compare Contingent Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,250.9 Cr | 4% | 10.3% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 4% |
10.3% |
-5.7% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses